It is reported that Lushang Development may divest its real estate development business and its business structure will be more focused on the big health business with cosmetics and biomedicine as the main business.
On January 30, Lushang Development released a performance forecast, expecting to achieve net profit attributable to shareholders of the listed company for the year 2022 of 18.0950 million yuan (about $2.7 million) to 54.2851 million yuan (about $8 million), compared with the same period of the previous year, it will decrease by 307.61057 million yuan (about $45.5 million) to 343.8858 million yuan (about $50.9 million), a decrease of 85% to 95%.
